BCDA Stock Earnings: BioCardia Beats EPS, Misses Revenue For Q4 2023

BioCardia Shocks Market with Mixed Earnings Report

BioCardia (NASDAQ:BCDA) has recently unveiled its performance for the final quarter of 2023, sending ripples through the market waters.

Surpassing all expectations, BioCardia posted an earnings per share of -9 cents, a feat that left analysts eating humble pie as they had projected a gloomier -11 cents.
However, the sweet taste of victory turned slightly bitter when the company revealed a revenue figure of $13,000, proving to be a bitter pill to swallow and landing a considerable 85.56% below the anticipated $90,000.

Delving into the data, InvestorPlace Earnings collates and dissects the nitty-gritty of quarterly reports, such as earnings per share and revenue, painting a clear picture of a company’s performance against analyst forecasts. The beauty lies in the automation of this process, enabling prompt dissemination of the latest financial figures to our readers. For any feedback or corrections, reach out to editor@investorplace.com.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/bcda-stock-earnings-biocardia-for-q4-of-2023/.

The Latest Buzz on BioCardia: Q4 2023 Earnings Analysis

Actionable Trade Ideas

BioCardia Shocks Market with Mixed Earnings Report

Swing Trading Ideas and Market Commentary

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Related Articles

WallStreet Waves

most Popular

trending right now